Brigit Riley
2021
Compensation breakdown
| Non-Equity Incentive Plan | $173,250 |
|---|---|
| Option Awards | $1,222,155 |
| Salary | $262,500 |
| Stock Awards | $99,200 |
| Other | $192,900 |
| Total | $1,950,005 |
Riley received $1.2M in option awards, accounting for 63% of the total pay in 2021.
Riley also received $173.3K in non-equity incentive plan, $262.5K in salary, $99.2K in stock awards and $192.9K in other compensation.
Rankings
In 2021, Brigit Riley's compensation ranked 6,136th out of 12,415 executives tracked by ExecPay. In other words, Riley earned more than 50.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,136 out of 12,415 | 51st |
Division Manufacturing | 2,600 out of 5,505 | 53rd |
Major group Chemicals And Allied Products | 1,134 out of 2,375 | 52nd |
Industry group Drugs | 1,009 out of 2,096 | 52nd |
Industry Biological Products, Except Diagnostic Substances | 244 out of 449 | 46th |
Pay ratio
| Brigit Riley's Pay | $1,950,005 |
|---|---|
| Median Employee's Pay | $188,229 |
| Pay Ratio | 10to 1 |
In 2021, the annual total compensation of Brigit Riley was $1,950,005.
The annual total compensation of the median employee at Avalanche Biotechnologies was $188,229.
The ratio of Brigit Riley's pay to the pay of median employee was therefore 10 to one.
Riley's colleagues
We found nine more compensation records of executives who worked with Brigit Riley at Avalanche Biotechnologies in 2021.
2021
Laurent Fischer
Avalanche Biotechnologies
Chief Executive Officer
2021
Christopher DeRespino
Avalanche Biotechnologies
Chief Financial Officer
2021
Angela Thedinga
Avalanche Biotechnologies
Chief Technology Officer
2021
Leone Patterson
Avalanche Biotechnologies
Chief Financial Officer
2021
Kishor Soparkar
Avalanche Biotechnologies
Chief Operating Officer
2021
Julie Clark
Avalanche Biotechnologies
Chief Medical Officer
2021
Rupert D'Souza
Avalanche Biotechnologies
Chief Financial Officer
2021
Thomas Leung
Avalanche Biotechnologies
Chief Financial Officer
2021
Jack Thrift
Avalanche Biotechnologies